Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha productionChristoph Gasche, Paul Grundtner, Petra Zwirn, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Prospective pilot study of recombinant granulocyte-macrophage colony-stimulating factor and interferon-gamma in patients with inoperable hepatocellular carcinomaWalter Reinisch, Margareta Holub, Andreas Katz, et al.Wiener Klinische Wochenschrift|December 17, 2008
Percutaneous ethanol instillation therapy for hepatocellular carcinoma - a randomized controlled trialChristian Müller, Maximilian Schöniger-Hekele, Rüdiger Schernthaner, et al.International Journal of Oncology|July 31, 2003
Chemoembolization with cisplatin, lipiodol and Gelfoam and subsequent systemic chemotherapy with cisplatin and interferon in patients with hepatocellular carcinoma: a non-randomized prospective studyMartina Baur, Reinhard Walter, Axel Gebauer, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 15, 2011
Portal pressure predicts outcome and safety of antiviral therapy in cirrhotic patients with hepatitis C virus infectionThomas Reiberger, Karoline Rutter, Arnulf Ferlitsch, et al.European Journal of Gastroenterology & Hepatology|February 1, 2003
Heterogeneous expression and regulation of CD40 in human hepatocellular carcinomaMargareta Holub, Schaker M Zakeri, Cornelia Lichtenberger, et al.Wiener Klinische Wochenschrift|November 2, 2004
Transjugular intrahepatic portosystemic shunt in Vienna--a decade laterBernhard Angermayr, Manfred Cejna, Franz Karnel, et al.Hepatology (Baltimore, Md.)|October 24, 2002
Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID miceMarkus F Wolschek, Christiane Thallinger, Malgorzata Kursa, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 5, 2003
Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapyPetra Steindl-Munda, Peter Ferenci, Harald Brunner, et al.Journal of Hepatology|December 13, 2005
Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infectionPeter Ferenci, Elisabeth Formann, Hermann Laferl, et al.Pageof 5